Real Clear Health: Drug Importation — High Risk, Low Reward

It’s tempting to think that legalizing drug importation would immediately give U.S. consumers access to medicines at the prices available in other developed countries. In reality, however, the Safe Importation Action Plan would expose American consumers to significant health risks while achieving meager cost reductions, if any at all. Visit Real Clear Health to lean […]

Townhall: Importing Drugs from Canada Would Kill Innovation and Could Cost Lives

In partnership with the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS) has recently proposed that certain pharmaceuticals should be cleared for import from Canada. Although the proposal seeks to lower prices for consumers, it poses critical unintended risks to both American businesses and patients. To read why, visit Townhall.

Open the Canadian Border for Drug Imports, and Dangerous Counterfeits will Follow

In an effort to reverse the continuing rise of prescription drug prices, the Food and Drug Administration (FDA) and the Department of Health and Human Services (DHHS) are mulling the idea of allowing drug imports from Canada. Their so-called “Safe Importation Action Plan,” however, is a misnomer—the policy could expose countless Americans to potentially deadly […]

Inside Sources: What Politicians Get Wrong About the Economics of Drug Importation

Last month, federal officials announced the Safe Importation Action Plan to legalize the importation of foreign drug products, including from Canada. However, the biggest concern with is proposal is that drug importation will expose American patients to unsafe, adulterated and counterfeit medicines from all over the world. To learn more, you can read this op-ed […]